SOUTH SAN FRANCISCO, Calif. & TOKYO--(BUSINESS WIRE)--Asterand plc (LSE: ATD), a leading provider of human tissue and human tissue-based services to pharmaceutical and biotechnology companies engaged in drug discovery, today announces that its subsidiary BioSeek, LLC, a pioneer in the application of predictive human biology to drug discovery, has signed a two-year collaboration agreement with Eisai Co., Ltd., a research-based human health care company headquartered in Japan.
